Finasteride Before and After: Real Hair Gains, a Small Risk That Won't Quit
What "After" Actually Looks Like
The before-and-after comparison for finasteride isn't dramatic overnight transformation. It's a slow, steady reclaiming of ground. At 1 mg per day, both investigators and patients rate visible improvement, and that 12 to 16 hairs per square centimeter gain at 6 to 12 months represents a meaningful shift in density.
A few details worth noting:
| Outcome | What the Research Shows |
|---|---|
| Hair count increase | +12–16 hairs/cm² at 6–12 months vs placebo |
| Visual improvement | Rated improved by both doctors and patients at 1 mg/day |
| 1 mg vs 5 mg daily | Similar results |
| Daily vs every-other-month | Daily dosing clearly better for maintaining density |
- Dose doesn't seem to matter much. 1 mg daily performs similarly to 5 mg daily and even to topical 1% finasteride for visual improvement.
- Consistency matters a lot. Daily dosing maintains density far better than very infrequent dosing, like every other month. If you're going to take it, taking it regularly is the point.
- The timeline is months, not weeks. Expecting visible change before 6 months is setting yourself up for disappointment.
The Side Effects Most People Actually Experience
At the 1 mg dose, finasteride is generally well tolerated. Most reviews describe it that way, and the majority of users either report no side effects or experience ones that resolve.
The short-term, typically reversible effects include:
- Decreased libido
- Erectile dysfunction
- Changes in ejaculation
These are real, but for most men they're manageable and fade either during use or after stopping. That's the baseline reality for the average user.
The Persistent Side Effect Question No One Can Fully Answer
Here's where the conversation gets thornier. Some men report a cluster of symptoms that continue months or even years after they stop finasteride. This has been labeled "post-finasteride syndrome" (PFS), and the reported symptoms go well beyond sexual function:
- Low libido and erectile dysfunction
- Genital numbness
- Anhedonia (inability to feel pleasure)
- Fatigue
- Cognitive fog
The problem is that the evidence for PFS comes mostly from small, biased, or self-selected samples. That doesn't mean these men aren't suffering. It means we can't confidently say how common this is, or even confirm that finasteride is definitively the cause. Causality and true frequency remain genuinely uncertain.
What is established is that regulatory agencies took the reports seriously enough to require label changes and warnings, specifically around depression and suicidal thoughts in men experiencing persistent sexual side effects. That's not nothing.
Topical Finasteride: A Lower-Risk Middle Ground?
If the systemic side effect profile concerns you, topical finasteride is worth knowing about. Applied directly to the scalp, alone or combined with minoxidil, it appears to offer similar hair benefits while suppressing far less DHT throughout the body.
| Route | Hair Benefit | Systemic DHT Suppression | Sexual Side Effect Risk |
|---|---|---|---|
| Oral (1 mg/day) | Well-established improvement | Higher | Small but documented |
| Topical (1%) | Similar visual improvement | Much lower | Reduced but still possible |
The catch: sexual side effects can still occur with topical use, and long-term data are limited. It's a promising option, not a guaranteed free pass.
Deciding Whether the Trade-Off Is Worth It
This is fundamentally a personal risk calculation, not a universal recommendation. The research supports a few clear positions:
The benefit is real but modest. Finasteride stabilizes and improves androgenetic alopecia. It won't give you a completely new head of hair, but it can meaningfully slow loss and add density.
The common risks are manageable for most. The majority of men tolerate 1 mg daily without lasting issues.
The uncommon risks are poorly understood but serious for those affected. If you develop persistent sexual symptoms, the available evidence can't tell you how likely recovery is, and mood effects including depression and suicidal ideation have been reported in that group.
A reasonable approach: talk with a clinician about your personal risk factors before starting, consider topical formulations if systemic exposure concerns you, and pay attention to changes in sexual function and mood early on. The men who run into the worst outcomes aren't necessarily identifiable in advance, which is exactly why informed, eyes-open decision-making matters more here than with many medications.
